Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
95% Confidence Interval
39%
Acne Keloidalis nuchae
16%
Adjusted Hazard Ratio
16%
Adjusted Odds Ratio
21%
Alopecia Areata
23%
Amyloidosis
11%
Ankylosing Spondylitis
11%
Anti-BP180
12%
Atopic Dermatitis
44%
Autoantibodies
15%
Autoimmune Bullous Disease
21%
Bidirectional Relationship
14%
Blister
11%
Bullous Pemphigoid
100%
Clinical Characteristics
12%
Clinical Outcomes
9%
Comorbid
12%
Comorbidity
12%
Control Subjects
20%
COVID-19
98%
Dipeptidyl peptidase-4 (DPP-4)
16%
Epidermolysis Bullosa Acquisita
17%
Hidradenitis Suppurativa
52%
Hospitalization
31%
IgA Pemphigus
13%
Immunological Characteristics
14%
Infantile Hemangioma
11%
Israel
23%
Large Cohort Study
17%
MRNA Vaccine
11%
Mucous Membrane Pemphigoid
11%
Multivariate Analysis
11%
Observational Prospective Study
11%
Odds Ratio
20%
Pemphigus
46%
Pemphigus Vulgaris
25%
Population-based Case-control Study
22%
Population-based Cohort Study
52%
Population-based Study
95%
Psoriasis
79%
Psoriatic Patients
18%
Pyoderma Gangrenosum
33%
Retrospective Cohort Study
49%
Rheumatoid Arthritis
17%
Risk Factors
9%
Schizophrenia
15%
Solid Malignancies
11%
Systemic Corticosteroids
12%
Treatment Outcome
11%
Vaccination
12%
Medicine and Dentistry
Acne Keloidalis Nuchae
16%
Alopecia Areata
16%
Asthma
7%
Atopic Dermatitis
31%
Autoantibodies
10%
Autoimmunity
21%
Biological Product
12%
Bullous Disease
19%
Bullous Pemphigoid
54%
Capillary Hemangioma
11%
Case-Control Study
34%
Cicatricial Pemphigoid
11%
Cohort Analysis
26%
Cohort Effect
8%
Comorbidity
31%
COVID-19
68%
Cross Sectional Study
15%
Dermatosis
14%
Diseases
24%
Epidermolysis Bullosa Acquisita
11%
Hazard Ratio
14%
Hidradenitis Suppurativa
28%
Hyperthyroidism
8%
Hypothyroidism
8%
IgA Pemphigus
6%
Inflammatory Infiltrate
6%
Lichen Planus
12%
Logistic Regression Analysis
10%
Metabolic Syndrome
6%
Morbidity
7%
Multivariate Analysis
7%
Nephropathy
7%
Odds Ratio
32%
Oral
13%
Patient Referral
6%
Pediatrics
6%
Pemphigus
16%
Pemphigus foliaceus
6%
Pemphigus vulgaris
15%
Prevalence
21%
Propranolol
11%
Prospective Study
22%
Pruritus
9%
Psoriasis
33%
Pyoderma gangrenosum
22%
Retrospective Cohort Study
38%
Rhinophyma
6%
Schizophrenia
22%
Systematic Review
22%
Thyroid Disease
12%
Immunology and Microbiology
Acantholysis
5%
Allergic Rhinitis
6%
Alopecia Areata
17%
Amyloidosis
11%
Ankylosing Spondylitis
11%
Asthma
6%
Atopic Dermatitis
25%
Autoantibodies
22%
Autoantigen
8%
Autoimmunity
17%
Biological Product
13%
Blister Fluid
5%
Blood Level
5%
Bullous Pemphigoid
87%
Cicatricial Pemphigoid
10%
Clostridium Botulinum Type A
5%
Cohort Effect
9%
Comorbidity
19%
COVID-19
54%
Dermatitis
5%
Dermatomyositis
6%
Dipeptidyl Peptidase IV
11%
Epidemiology
8%
Granulocyte
5%
Hidradenitis Suppurativa
18%
Hypogammaglobulinemia
5%
IgA Pemphigus
12%
Immunoglobulin A
8%
Immunoglobulin M
5%
Infection
19%
Infectious Disease
19%
Inflammatory Arthritis
17%
Leukocyte Activation
5%
Lichen Planus
6%
Neutrophil
7%
Pemphigoid
11%
Pemphigus
50%
Pemphigus foliaceus
7%
Pemphigus vulgaris
18%
Polymyositis
5%
Prevalence
20%
Red Blood Cell Distribution Width
5%
Rituximab
7%
Rupatadine
5%
Seborrhoeic Dermatitis
5%
Seropositivity
10%
Systemic Lupus Erythematosus
5%
Therapeutic Target
5%
TNF Inhibitor
8%
Ulcerative Colitis
6%